Webside score beigene.com
Advancing Cancer Care Through Science & Purpose | BeOne Medicines
Genereret Marts 16 2026 20:57 PM
Gammel data? OPDATER !
Scoren er 54/100
SEO Indhold
Titel
Advancing Cancer Care Through Science & Purpose | BeOne Medicines
Længde : 65
Perfekt, din titel indeholder mellem 10 og 70 bogstaver.
Beskrivelse
BeOne Medicines, formerly BeiGene, is committed to advancing cancer care through a science‑led, purpose‑driven model that improves treatment access for patients worldwide.
Længde : 171
Kan optimeres; din meta beskrivelse bør indeholde mellem 70 og 160 karakterer (med mellemrum). Brug dette gratis redskab til at regne længden ud.
Nøgleord
Dårligt! Vi kan ikke finde nogle meta nøgleord på din side! Brug denne gratis online meta generator for at oprette nye nøgleord.
Og Meta Egenskaber
Godt, din side benytter Og egenskaberne
| Egenskab | Indhold |
|---|---|
| locale | en_US |
| type | website |
| title | Advancing Cancer Care Through Science & Purpose | BeOne Medicines |
| description | BeOne Medicines, formerly BeiGene, is committed to advancing cancer care through a science‑led, purpose‑driven model that improves treatment access for patients worldwide. |
| url | https://beonemedicines.com/ |
| site_name | BeOne |
Overskrifter
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 7 | 1 | 16 | 0 | 14 |
- [H1] Transforming How The World Fights Cancer
- [H2] Leading Cancer Research Worldwide
- [H2] Driving Change for People With Cancer
- [H2] BeOne News
- [H2] Be You. Be Change. BeOne.
- [H2] Participate in Research
- [H2] EXTERNAL LINKS
- [H2] EXTERNAL LINKS
- [H3] Discover our nearly 50 abstracts at ASH 2025.
- [H4] Living with Cancer: Richard’s Story
- [H4] Living with Cancer: Geoff and Tina’s story
- [H4] Building a Breast Cancer Pipeline With Purpose
- [H4] A Culture That Enables Innovation
- [H4] BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting…
- [H4] BeOne Medicines to Present at Upcoming Investor Conferences
- [H4] BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results…
- [H4] BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare…
- [H4] ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+…
- [H4] BeOne Medicines’ Novel BCL2 Inhibitor, Sonrotoclax, Achieves First-in-World Approval in R/R MCL…
- [H4] BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
- [H4] BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment…
- [H4] BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic…
- [H4] Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
- [H4] U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed…
- [H4] BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025
- [H6] February 26, 2026
- [H6] February 17, 2026
- [H6] February 11, 2026
- [H6] January 13, 2026
- [H6] January 6, 2026
- [H6] January 6, 2026
- [H6] December 23, 2025
- [H6] December 18, 2025
- [H6] December 8, 2025
- [H6] December 7, 2025
- [H6] November 26, 2025
- [H6] November 20, 2025
- [H6] Careers
- [H6] Clinical Trials
Billeder
Vi fandt 14 billeder på denne side.
Godt, de fleste eller alle af dine billeder har ALT tags.
Text/HTML balance
Balance : 11%
Denne sides text til HTML fordeling er under 15 procent, dette betyder at din side mangler indhold!
Flash
Perfekt, ingen Flash objekter er blevet fundet på siden.
iFrame
Beklager! Din side har iFrames og det kan medføre i yderst dårlig læsning af søgerobotterne.
SEO Links
URL Omskrivning
Godt. Dine links ser venlige ud!
Underscores i links
Perfekt! Ingen underscores blev fundet i dine links
On-page links
Vi fandt et total af 82 links inkluderende 0 link(s) til filer
| Anker | Type | Juice |
|---|---|---|
| Contact Us | Intern | Sender Juice |
| Adverse Events | Intern | Sender Juice |
| Newsroom | Intern | Sender Juice |
| Corporate Press Kit | Intern | Sender Juice |
| Product & Pipeline Media Resources | Ekstern | Sender Juice |
| Media Library | Intern | Sender Juice |
| Global | Intern | Sender Juice |
| Argentina | Ekstern | Sender Juice |
| Australia | Ekstern | Sender Juice |
| Austria | Ekstern | Sender Juice |
| Brazil | Ekstern | Sender Juice |
| EN | Ekstern | Sender Juice |
| FR | Ekstern | Sender Juice |
| China | Ekstern | Sender Juice |
| Denmark | Ekstern | Sender Juice |
| Finland | Ekstern | Sender Juice |
| France | Ekstern | Sender Juice |
| Germany | Ekstern | Sender Juice |
| Italy | Ekstern | Sender Juice |
| Japan | Ekstern | Sender Juice |
| MENA | Ekstern | Sender Juice |
| Netherlands | Ekstern | Sender Juice |
| Norway | Ekstern | Sender Juice |
| Singapore | Ekstern | Sender Juice |
| South Africa | Ekstern | Sender Juice |
| South Korea | Ekstern | Sender Juice |
| Spain | Ekstern | Sender Juice |
| Sweden | Ekstern | Sender Juice |
| DE | Ekstern | Sender Juice |
| FR | Ekstern | Sender Juice |
| IT | Ekstern | Sender Juice |
| UK | Ekstern | Sender Juice |
| United States | Ekstern | Sender Juice |
| About Us | Intern | Sender Juice |
| Our History | Intern | Sender Juice |
| Leadership | Intern | Sender Juice |
| Our Stories | Intern | Sender Juice |
| Our Offices | Intern | Sender Juice |
| Partnering | Intern | Sender Juice |
| Manufacturing | Intern | Sender Juice |
| Our Medicines | Intern | Sender Juice |
| Research & Development Overview | Intern | Sender Juice |
| Disease Focus Areas: Hematology | Intern | Sender Juice |
| Disease Focus Areas: Solid Tumors | Intern | Sender Juice |
| Pioneering Protein Degradation with CDACs | Ekstern | Sender Juice |
| Antibody Drug Conjugates | Ekstern | Sender Juice |
| Pipeline | Intern | Sender Juice |
| Find a Trial | Intern | Sender Juice |
| Becoming an Investigator | Intern | Sender Juice |
| Investigator-Initiated Trial | Intern | Sender Juice |
| BeCollective HCP Network | Intern | Sender Juice |
| Collaborations | Ekstern | Sender Juice |
| Our Commitment to Patients | Intern | Sender Juice |
| Patient Support Program | Intern | Sender Juice |
| Expanded Access Program | Intern | Sender Juice |
| Cancer & Mental Health | Intern | Sender Juice |
| Global Patient Safety | Intern | Sender Juice |
| Responsibility and Sustainability | Intern | Sender Juice |
| Advancing Global Health | Intern | Sender Juice |
| Empowering Our Colleagues | Intern | Sender Juice |
| Innovating Sustainably | Intern | Sender Juice |
| Operating Responsibly Overview | Ekstern | Sender Juice |
| Policies & Positions | Intern | Sender Juice |
| Suppliers | Intern | Sender Juice |
| Global Transparency | Intern | Sender Juice |
| Giving Overview | Ekstern | Sender Juice |
| BeOne Care Foundation | Intern | Sender Juice |
| Independent Medical Education Grants | Intern | Sender Juice |
| Careers | Intern | Sender Juice |
| Our Culture | Intern | Sender Juice |
| Visit our congress hub to learn more | Ekstern | Sender Juice |
| Contact Us | Intern | Sender Juice |
| Newsroom | Intern | Sender Juice |
| NASDAQ Investors | Ekstern | Sender Juice |
| HKEX Investors | Ekstern | Sender Juice |
| SSE Investors | Ekstern | Sender Juice |
| Medical Information | Ekstern | Sender Juice |
| NASDAQ Investors | Intern | Sender Juice |
| HKEX Investors | Intern | Sender Juice |
| SSE Investors | Intern | Sender Juice |
| Terms of Use | Intern | Sender Juice |
| Privacy Policy | Intern | Sender Juice |
SEO Nøgleord
Nøgleords cloud
global newsroom cancer south beone media patients research world press
Nøgleords balance
| Nøgleord | Indhold | Titel | Nøgleord | Beskrivelse | Overskrifter |
|---|---|---|---|---|---|
| global | 8 |  |
|
|
 |
| cancer | 6 | |
|
|
|
| newsroom | 5 | |
|
|
|
| press | 5 | |
|
|
|
| beone | 4 | |
|
|
|
Brugervenlighed
Link
Domæne : beigene.com
Længde : 11
FavIkon
Godt, din side har et FavIcon!
Printervenlighed
Vi kunne ikke finde en printer venlig CSS skabelon.
Sprog
Godt, dit tildelte sprog er en.
Dublin Core
Denne side benytter IKKE Dublin Core principperne.
Dokument
Dokumenttype
HTML 5
Kryptering
Perfekt. Dit Charset er tildelt UTF-8.
W3C Validering
Fejl : 0
Advarsler : 0
Email Privatliv
Advarsel! Mindst én email adresse er blevet fundet i rå tekst. Brug gratis antispam beskytter for at hemme din email fra spammere.
Udgået HTML
Godt! Vi har ikke fundet udgåede HTML tags i din kildekode
Hastigheds Tips
|
Alle tiders! Din webside bruger ikke nestede tabeller. |
|
Advarsel! Din webside benytter inline CSS kode! |
|
Dårligt, din webside har for mange CSS filer (mere end 4). |
|
Dårligt, din webside har for mange JavaScript filer (mere end 6). |
|
Perfekt, din hjemmeside udnytter gzip. |
Mobil
Mobil Optimering
|
Apple Ikon |
|
Meta Viewport Tag |
|
Flash indhold |
Optimering
XML Sitemap
Stor, din hjemmeside har en XML sitemap.
| https://beonemedicines.com/sitemap_index.xml |
Robots.txt
https://beigene.com/robots.txt
Stor, din hjemmeside har en robots.txt-fil.
Analytics
Mangler
Vi har ikke registrerer en analyseværktøj installeret på denne hjemmeside.
Web analytics kan du måle besøgendes aktivitet på dit websted. Du bør have mindst én analyseværktøj installeret, men det kan også være godt at installere et sekund for at krydstjekke data.
PageSpeed Insights
Apparat
Kategorier
Free SEO Testing Tool
Free SEO Testing Tool er et gratis SEO redskab der hjælper med din hjemmeside